Navigation Links
Teen smoking-cessation trial first to achieve significant quit rates
Date:10/12/2009

own reasons and desire to quit that motivate the quit attempt," said Kealey, project manager for the study.

Cognitive behavioral skills training seeks to help people build skills for quitting and preventing relapse through counseling strategies that emphasize practical tools, such as self-talk strategies, ways to cope with stress and smoking triggers, and collaborating on a plan for quitting. "While motivational interviewing increases a person's motivation to quit, cognitive behavioral skills training gives them the resources and the confidence they need to be successful," Kealey said.

Adolescent smoking cessation studies conducted in the past 20 years have been largely unsuccessful in getting teens to quit. These studies have identified significant challenges. To date, only two other randomized controlled trials with smaller numbers of teen smokers than the Hutchinson Study and conducted in medical settings have shown promise in achieving significant teen quit rates.

So what makes the Hutchinson Study so effective? The researchers hypothesize that the reason is threefold:

The intervention was proactive, reaching out and engaging teens "Past research has shown that, for a multitude of reasons, many teen smokers do not seek out help with quitting. However, our study demonstrates that if we reach out to teens, without pressuring them to quit, many will talk to counselors about their smoking and some of those teens will decide to quit," Peterson said.

The counseling was offered by telephone "This allowed for private, confidential, one-to-one counseling and allowed the counselors to explore and focus on issues specific to the individual smoker," he said. Telephone counseling also gave teens control over the timing and length of the counseling sessions.

The counselors used motivational interviewing techniques in all communications with the teens "It seemed quite appropriate for us to test this deferential strategy in
'/>"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
Source:Eurekalert

Page: 1 2 3 4 5

Related medicine news :

1. Recent smoking-cessation research highlights importance of keeping teens from smoking
2. New Heart Pump Shows Promise in Trial
3. Trial to Test Gene Therapy for Angina in Women
4. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
5. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
6. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
7. MDS Pharma Services Wins Award for Management of Global Malaria Trial
8. New Ovarian Cancer Drug Trial Under Way
9. Study Questions Dead-End Cancer Clinical Trials
10. AtriCure Reports First Human Implant of the Cosgrove-Gillinov Left Atrial Appendage Occlusion System
11. CryoCor Invited to Participate in FDA Advisory Panel Meeting on Atrial Fibrillation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Carnegie Science Center and ... partnership to develop BodyTech, a dynamic, three-pronged health and ... a new exhibit at the Science Center called BodyWorks, ... new traveling science show, Anatomy Adventure, which will hit ... Designed to explore a wide range of topics surrounding ...
(Date:5/22/2015)... May 22, 2015 Power Systems is proud ... the 2015 race season. Drobeck is in his second year ... a firefighter with the Missoula Fire Department in Missoula, MT. ... Pro in 2014. During his career, he has had 15 ... Drobeck recorded top 10 finishes in all seven of his ...
(Date:5/22/2015)... May 22, 2015 The ... Dental announces that they are now offering complimentary ... other dental treatments. At consultations, patients can discuss ... regarding what certain treatments can achieve and whether ... during this initial appointment. If treatments are chosen, ...
(Date:5/22/2015)... A Phase 3 French study, which ... Clinical Oncology (ASCO)’s annual meeting at the end ... patients who received bevacizumab in addition to the ... Genentech, Inc.) is an antibody that blocks angiogenesis ... used to treat many other cancers, including lung ...
(Date:5/22/2015)... 22, 2015 In an effort to ... Sons is offering to donate $5 dollars for every ... unit or water softening system. Customers have their needs ... Sons gets business; and the Special Olympics receives money. ... Olympics helps over 4.4 million athletes, and boasts a ...
Breaking Medicine News(10 mins):Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 2Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 3Health News:Carnegie Science Center, Allegheny Health Network Partner to Create BodyTech 4Health News:West Hollywood Dental Office, Sunset Plaza Dental is Now Offering Complimentary Consultations 2Health News:Mesothelioma Research Organization Excited About Imminent Improvement to Standard of Care 2Health News:Parker and Sons is Proud to Support the Special Olympics with Their Everybody Wins Program 2
... the aim to combat AIDS will exploit the unused power ... to aid research and identify drugs used to combat the ... called FightAIDS@Home, aims to enlist about 100,000 computer users to ... when they would otherwise be idle., ,This ...
... to protect Americans from bird flu and other diseases, ... and shipping firms to hand over// passenger and crew ... illnesses., ,The Atlanta-based Centers for Disease Control and ... responding to health threats, has proposed the regulatory overhaul. ...
... duration of breast-feeding is associated with reduction in risk ... Previous studies have already provided evidence for improved insulin ... to their counterparts. ,The study is the first ... between lactation and Type 2 diabetes. More than 1,57,003 ...
... Conservative groups in the United States, who had voiced ... "morning-after" pill, are now having no such qualms about ... manufactured by Merck & Co. and GlaxoSmithKline are still ... the market, but concerns had been voiced about them ...
... Rs 300 million to Christian Medical College (CMC), Vellore, to ... see if stem cells can be developed into heart muscles, ... specialized cells. , ,"It is a matter of great ... project. It will have far-reaching implications in the lives of ...
... Mayo Clinic, in Olmsted County, Minnesota, suggest that Parkinson's ... manual workers,// meaning that an individual's educational and career ... ,The researchers said that probably early Parkinson's triggered a ... than long periods of education increasing susceptibility to the ...
Cached Medicine News:Health News:U.S. To Tighten Sick Passenger, Quarantine Rules 2Health News:Breastfeeding To Reduce Risk Of Type 2 Diabetes 2Health News:Religious groups overcome objections to cervical cancer vaccines 2
(Date:5/22/2015)... BOSTON , May 22, 2015  In a ... in the U.S., T1D Exchange researchers conclude ... in type 1 diabetes across all age groups, but ... the most up-to-date picture of diabetes treatment, underscoring the ... therapies and technologies that can help type 1 patients ...
(Date:5/21/2015)... CHICAGO , May 21, 2015 /PRNewswire-USNewswire/ ... lump along the side of his neck, ... and took a couple weeks off from ... didn,t go away.                               ... Rendino, 26, was referred to Michel ...
(Date:5/21/2015)... CITY, Calif. , May 21, 2015  Cardica, Inc. ... 2015, new employee Greg Watson , the company,s vice ... shares of the company,s common stock, at a per share ... 20, 2015. The stock option was granted pursuant to Cardica, ... of directors in May 2015 under Rule 5653(c)(4) of the ...
Breaking Medicine Technology:Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 2Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 3Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 4Study Reveals Poor Disease Control Among Adolescents and Young Adults with Type 1 Diabetes 5Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 2Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 3Northwestern Medicine Surgeons Develop New Approach to Removing Nerve Tumors 4Cardica Announces New Employment Inducement Grant 2
... a clinical study of adults, VYVANSE taken once-daily ... PHILADELPHIA, Oct. 7 Shire plc (LSE: ... that a study published in the September issue ... significantly improved,Attention Deficit Hyperactivity Disorder (ADHD) symptoms in ...
... - Data Presented Today at ACG Annual Scientific ... Ironwood,Pharmaceuticals, Inc. (formerly Microbia, Inc.) and Forest Laboratories,Inc. ... of results from a Phase,2b study assessing linaclotide,s ... syndrome with constipation (IBS-C). Analysis of the data,indicates ...
Cached Medicine Technology:Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 2Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 3Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 4Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 5Study Published in Journal of Clinical Psychiatry Showed Once-Daily VYVANSE(R) (lisdexamfetamine dimesylate) Significantly Improved ADHD Symptoms in One of the Largest Controlled Stimulant Trials in Adults with ADHD 6Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 2Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 3Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 4Ironwood and Forest Present Positive Phase 2b Study Results for Linaclotide in Patients With Irritable Bowel Syndrome With Constipation 5
The DSL-05-01-MEM Measles IgM Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgM-class antibodies to Measles virus in human serum. This assay is intended fo...
... The Diagnostic Automation, Inc.. (DAI) Measles IgG ... the detection and quantitative determination of IgG ... sera. Individual serum specimens may be ... Paired sera, acute and convalescent, may be ...
The DSL-05-10-MEG Measles IgG Enzyme-Linked Immunosorbent Assay (ELISA) kit provides materials for the determination of IgG-class antibodies to Measles Virus in human serum. This assay is intended fo...
... The Vitros Cortisol Range Verifiers have ... System with,the Vitros Immunodiagnostic Products Cortisol Reagent ... range verifiers contain low and,high cortisol concentrations, ... range, and can be used,to verify measurement ...
Medicine Products: